SEC EDGAR · Company announcement
EMR: Financial results
Filed 8-K for an event or period dated 2026-10-13. Financial results.
Follow EMR- Became public
- Oct 13, 2026, 6:57 AM EDT
- Event / period date
- Oct 13, 2026
- Collected
- Nov 8, 2026, 1:07 AM EST
Why this is connected
This filing identifies EMERSON ELECTRIC CO as the issuer of the security. The company's SEC identifier connects it to EMR.
Source evidence
Read the source excerpt or record
Item 2.02 Results of Operations and Financial Condition (Dollars in millions, except per share amounts) On October 13, 2026, Emerson Electric Co. ("Emerson" or the "Company") announced that, effective for the fiscal year ended September 30, 2026, it has elected to change its method of accounting for actuarial gains and losses associated with its defined benefit pension and other postretirement benefit plans. Under the new method, commonly referred to as mark-to-market accounting, actuarial gains and losses will be recognized in earnings in the period in which they arise. Historically, Emerson recognized actuarial gains and losses in accumulated other comprehensive income and amortized a portion of those amounts into net periodic benefit cost in subsequent periods. Beginning in the fourth quarter of fiscal 2026, the Company will recognize actuarial gains and losses annually in the fourth quarter based on the plans' September 30 annual measurement date. The annual mark-to-market adjustment will principally reflect changes in discount rates, returns on plan assets and other actuarial assumptions. Emerson believes the new method is preferable under U.S. generally accepted accounting principles ("U.S. GAAP") because it improves the transparency of the Company's results of operations by recognizing the effects of current economic conditions and pla n experience in the period in which they arise, rather than amortizing those effects into earnings over future periods. The new method also better aligns the measurement of pension and other postretirement benefit expense with fair value principles. The Company expects to record a pretax gain of less than $5 for the mark-to-market adjustment in the fourth quarter of fiscal 2026 based on its current actuarial assumptions and estimatCongressional trading in EMR
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Oct 13, 2026$15K–$50K
Rep. Kevin Hern (R-OK-1)
Sold (partial) Emerson Electric EMR
$15K–$50K · Traded Sep 17, 2026 · disclosed Oct 13, 2026 · Joint
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 25, 2026 · disclosed Oct 7, 2026 · Spouse
- Sep 25, 2026$1K–$15K
Rep. Kevin Hern (R-OK-1)
Sold (partial) Emerson Electric EMR
$1K–$15K · Traded Sep 14, 2026 · disclosed Sep 25, 2026 · Joint
- Sep 25, 2026$15K–$50K
Rep. Kevin Hern (R-OK-1)
Sold (partial) Emerson Electric EMR
$15K–$50K · Traded Sep 14, 2026 · disclosed Sep 25, 2026 · Joint
- Aug 14, 2026$1K–$15K
Rep. Richard McCormick (R-GA-7)
$1K–$15K · Traded Jul 30, 2026 · disclosed Aug 14, 2026
Traded 5 days before earnings - Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
- May 11, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Apr 13, 2026 · disclosed May 11, 2026 · Spouse
- Feb 6, 2026$15K–$50K
Rep. Ro Khanna (D-CA-17)
$15K–$50K · Traded Jan 29, 2026 · disclosed Feb 6, 2026 · Spouse
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.